10-QPeriod: Q1 FY2010

3M CO Quarterly Report for Q1 Ended Mar 31, 2010

Filed May 5, 2010For Securities:MMM

Summary

3M Company reported a strong first quarter in 2010, with net sales of $6.35 billion, a significant increase of 24.7% compared to the same period in 2009. This growth was driven by broad-based improvements across all business segments and geographic regions, with particular strength in Asia Pacific and Latin America/Canada. The company experienced robust organic sales volume growth of 19.2%, outpacing global economic indicators and suggesting market share gains supported by new products and technologies. Profitability also saw substantial improvement, with operating income rising by 79.9% to $1.45 billion. This was achieved through a combination of increased sales, improved factory utilization, cost savings from prior restructuring actions, and enhanced operational efficiencies. The company's effective tax rate increased slightly to 31.9% due to a one-time non-cash tax charge related to the new healthcare legislation, but underlying international tax benefits and other adjustments helped manage the overall rate. 3M maintained a strong financial position with healthy operating cash flows of $1.08 billion and ample liquidity.

Financial Statements
Beta

Key Highlights

  • 1Net sales increased by a significant 24.7% to $6.35 billion in Q1 2010 compared to Q1 2009.
  • 2Operating income saw a substantial rise of 79.9% to $1.45 billion, indicating strong margin expansion.
  • 3Organic sales volume grew by 19.2%, demonstrating robust demand and potential market share gains.
  • 4All six business segments reported strong sales growth, with Display and Graphics, Electro and Communications, and Industrial and Transportation leading the way.
  • 5The company generated $1.08 billion in cash from operating activities, reflecting strong cash generation capabilities.
  • 6A one-time, non-cash income tax charge of $84 million (or $0.11 per diluted share) was recorded due to the Patient Protection and Affordable Care Act.
  • 73M continues to invest in growth initiatives, including R&D and acquisitions, while maintaining a disciplined approach to capital allocation.

Frequently Asked Questions

3M's sales growth in Q1 2010 was driven by a combination of factors including a broad economic recovery, strong performance in emerging economies (particularly Asia Pacific and Latin America/Canada), significant organic sales volume growth of 19.2%, market share gains, successful new product introductions, and favorable currency translation effects.

Profitability improved significantly, with operating income increasing by 79.9% to $1.45 billion. This was due to higher sales volumes, improved factory utilization, cost savings from prior restructuring initiatives, and increased operational efficiencies, leading to a substantial expansion in operating income margins from 15.8% in Q1 2009 to 22.8% in Q1 2010.

The Patient Protection and Affordable Care Act, enacted in March 2010, resulted in a one-time, non-cash income tax charge of $84 million (approximately $0.11 per diluted share). This charge was due to a reduction in the value of the company's deferred tax asset related to changes in the tax treatment of Medicare Part D reimbursements.

3M maintained a strong financial position with $1.08 billion in operating cash flow for the quarter. The company has ample liquidity, with $5.2 billion in cash, cash equivalents, and marketable securities, and a manageable debt level. They continue to invest in growth, consider acquisitions, and return capital to shareholders through dividends and share repurchases, while maintaining strong credit ratings.